Knowledge

3 Periorbital Polishing Techniques: Fine Line Eradication and Business Economics of the ULTHERA DS 10-1.5N Transducer

Posted on by admin5

In the evolving landscape of medical aesthetics, demand for non-invasive eye and lip rejuvenation has surged. Clinical data demonstrates that superficial microfocused ultrasound with visualization (MFU-V) can significantly improve periocular and perioral fine lines after a single treatment. However, operating within thin skin zones over bone demands immense device-side precision. Practices are shifting away from generic high-intensity focused ultrasound (HIFU) probes toward branded Ultherapy transducers that feature controlled focal depths, integrated imaging, and standardized energy delivery.

The ULTHERA DS 10-1.5N (10 MHz, 1.5 mm narrow) transducer is engineered specifically for this superficial, small-field clinical work. It creates micro-focused ultrasound coagulation points in the superficial dermis while minimizing collateral heating near critical structures. For clinic owners and biomedical engineers, optimizing this handpiece requires balancing precise clinical execution with structured line-count economics and vendor-backed technical maintenance.

ALLWILL stabilizes global B2B access to certified Ulthera consumables and replacement handpieces. Sourcing components through a verified supply chain and testing them via advanced engineering environments allows medical practices to safely integrate high-density polishing protocols into their daily clinical workflows.

What It Does and Ideal Clinic Profile

The DS 10-1.5N is a 10 MHz, 1.5 mm depth DeepSEE transducer designed with a narrow patient contact footprint (N type). It targets the superficial dermis while maintaining ultrasound visualization up to a depth of 8 mm. The system produces linear arrays of discrete thermal coagulation points (TCPs) at an approximate 1.5 mm depth, maintaining beam widths at focus in the 0.24–0.25 mm range. In clinical workflows, this handpiece is deployed to refine fine periorbital and perioral rhytids, complementing deeper 3.0 mm and 4.5 mm cartridges rather than acting as a standalone lifting solution.

Medical practices that derive the highest return on investment from this accessory include:

  • Facial plastic surgery clinics, dermatology practices, and high-end medspas that already offer full-face Ultherapy protocols and require enhanced finesse for crow’s feet and perioral barcode lines.

  • Practices treating a significant percentage of thin-skinned, lower-BMI patients, such as specific Asian and peri-menopausal demographics, where narrow focal zones and bone avoidance are clinically critical.

  • Established clinics seeking to increase overall ticket value and patient satisfaction by introducing a superficial wrinkle refinement tier without investing in an entirely new technology platform.

Integrating the DS 10-1.5N transforms an existing console into a revenue-multiplying asset, provided procurement, line costs, and hardware maintenance are managed systematically.

Definition: What is 3 Periorbital Polishing?

3 Periorbital polishing refers to a structured, three-axis clinical approach to treating the crow’s feet complex—encompassing the lateral canthus, the infra-orbital hollow margins, and the upper cheek transition zones—using the red 10 MHz, 1.5 mm ULTHERA DS 10-1.5N transducer. This methodology delivers microfocused ultrasound energy precisely into the upper dermis. The narrow focal geometry restricts the lateral spread of the acoustic field, allowing practitioners to smooth etched, static wrinkles in ultra-thin tissue with greater control and anatomical safety than standard broad-beam energy devices.

Clinical Pain Points in Thin Periorbital Anatomy

Periorbital and perioral skin morphology often presents a thickness of less than 1 mm, characterized by minimal subcutaneous fat cushioning and close proximity to the orbital rim, periosteum, and neurovascular pathways. Generic aesthetic cartridges featuring wider focal zones or deep, fixed heating patterns risk delivering thermal injury too close to the epidermis or directly onto bone. This can result in localized pain, persistent swelling, or post-inflammatory hyperpigmentation, particularly in darker skin phototypes.

Simultaneously, patient expectations have shifted toward immediate, high-fidelity smoothing of static lines without the social downtime, bruising, or injection-related anxiety associated with traditional dermal fillers or ablative resurfacing lasers.

Operationally, standard multi-depth protocols using 4.5 mm and 3.0 mm configurations focus primarily on structural lifting and deep tissue tightening. They do not safely accommodate high-density, line-by-line textural refinement around delicate facial contours. Consequently, clinics often undertreat these areas to preserve safety margins, compromising visible outcomes and patient retention. This challenge is frequently compounded by a fragmented secondary supply chain, where inconsistent access to certified, technically validated 1.5 mm cartridges prevents practices from establishing predictable, scalable treatment protocols.

Technical Specification and Cartridge Comparison

The clinical utility of the ULTHERA DS 10-1.5N rests on how its narrow focal zone geometry alters energy delivery compared to alternative aesthetic modalities.

Technical Aspect ULTHERA DS 10-1.5N (Red, Narrow) Conventional 1.5 mm HIFU Probe Fractional Non-Ablative Laser
Frequency and Depth 10 MHz frequency focused at 1.5 mm into the upper dermis for fine line targeting. Typically 4–7 MHz with broad depth variations across the 1.5–3.0 mm zone. Optical energy targeting the epidermis and papillary dermis layers.
Focal Zone Geometry Narrowed “N” footprint designed for tight periorbital and perioral zones. Wide lateral thermal spread, increasing proximity risks near bone. Pixelated microbeams creating fractional columns without localized depth specificity.
Real-Time Imaging Integrated with DeepSEE real-time ultrasound visualization up to 8 mm. Lacks integrated imaging; line placement relies entirely on surface anatomy. Uses surface guides only; provides no sub-surface tissue visualization.
Primary Indications Superficial periorbital wrinkles, crow’s feet polishing, and perioral etching. General tissue tightening; less optimal for delicate, superficial lines. Epidermal texturing, pigment modulation, and mild superficial tightening.
Downtime and Tolerance Mild, transient erythema; single-session protocol with minimal disruption. Elevated risk of focal tenderness or deep periosteal aching if misplaced. Post-treatment erythema, mild edema, and potential micro-crusting over several days.
Sourcing and Validation B2B procurement backed by multi-point engineering inspections via ALLWILL. Variable manufacturing quality and uncertain line count integrity depending on source. Widely distributed; performance relies heavily on manufacturer service networks.
Also check:  L&CBio MegaDerm Price & Sourcing Guide for Hospital-Grade Regenerative Surgery

Functional Breakdown: How the Technology Operates

The clinical and economic efficiency of the DS 10-1.5N depends on three integrated hardware and software characteristics.

1. Superficial Dermal Targeting

By operating at a high frequency of 10 MHz, the transducer concentrates acoustic energy at a shallow 1.5 mm depth plane. This focus allows for precise dermal collagen remodeling and neocollagenesis directly beneath the epidermis, avoiding deeper subcutaneous layers or SMAS structures. This depth matches the structural anatomy where fine static lines form around the lateral canthal and perioral zones.

2. Narrow “N” Footprint Architecture

While the standard DS 10-1.5 and the narrow DS 10-1.5N share identical acoustic parameters, the “N” version reduces the active scan length to approximately 14 mm compared to the standard 25 mm footprint. Shortening the treatment line enables precise positioning over curved bony structures like the orbital rim and zygoma. It minimizes the lateral spread of thermal coagulation points, allowing clinicians to safely place high-density, overlapping patterns without causing unintended thermal compounding in thin tissue.

3. Integrated SEE-PLAN-TREAT Visualization

The handpiece syncs with the core console’s DeepSEE technology, giving operators the ability to visualize tissue layers, confirm acoustic coupling, and map out bone proximity prior to and during energy delivery. This supports a structured, three-layer approach where superficial polishing passes are layered precisely over deeper 3.0 mm and 4.5 mm structural treatments without relying on blind anatomical estimation.

Step-by-Step Clinical Implementation Protocol

To achieve safe results and maximize patient satisfaction, practices should follow a structured sequence when executing a 3 periorbital polishing protocol.

1. Baseline Assessment and Selection

Evaluate the patient’s static and dynamic rhytids, baseline skin thickness, and historical cosmetic treatments. Ideal candidates exhibit mild-to-moderate static lines around the eyes or mouth and possess realistic expectations regarding the 90–180 day timeline required for natural collagen synthesis.

2. Hardware Verification and Preparation

Calibrate the console and mount the verified ULTHERA DS 10-1.5N transducer. Check the starting line count, lot number, and membrane integrity. Utilizing components validated by an engineering-focused supplier helps ensure that acoustic output matches original specifications.

3. Anatomical Mapping and Imaging

Cleanse the treatment zone and apply a standardized ultrasound coupling gel. Use the real-time visualization monitor to evaluate dermal boundaries and identify underlying bone structures. Mark out the three targeted sub-zones: the lateral crow’s feet fan, the infra-orbital region, and the upper cheek transition zone.

4. Parameter Selection and Line Planning

Configure energy parameters based on tissue feedback and patient tolerance. Initial energy levels typically stay under 1.5 J at 10 MHz, with maximum power limited to 15 W. Plan for higher line densities inside deeply etched static lines, and shift to conservative line spacing near safety boundaries like the lower lash margin.

5. Execution of Polishing Passes

Deliver the lines systematically across the mapped zones. Maintain firm, perpendicular transducer contact to eliminate air gaps or fluid pockets that can cause surface burns. When performing combination therapies, complete all deep 4.5 mm and 3.0 mm lifting passes first, then finish with the 1.5 mm superficial polishing pass.

6. Post-Treatment Logging and Follow-Up

Record the final line counts, total energy delivered, and immediate skin responses in the patient chart. Provide clear guidelines regarding transient redness or localized mild tenderness. Schedule a follow-up assessment at the 3-month to 6-month interval to track objective texturing improvements via clinical photography.

Practical Clinical Use Cases

Integrating this precise technology allows practices to address patient scenarios that are difficult to manage using traditional treatments alone.

Use Case 1: Early Crow’s Feet in a Professional Patient

  • Traditional Approach: The clinic administers botulinum toxin alone or performs deep 3.0 mm/4.5 mm MFU-V passes. While deep passes improve structural laxity, they leave fine, etched superficial static lines unaddressed, and toxin injections may alter natural dynamic expressions.

  • Adopting the DS 10-1.5N Protocol: The clinician adds a targeted superficial polishing pass over the lateral canthal fan using the narrow 1.5 mm cartridge. This softens surface lines while maintaining natural facial movement and avoiding social downtime.

Also check:  How Can Skin Rejuvenation Devices Transform Your Practice?

Use Case 2: Crepey Infra-Orbital Skin in a Laser-Averse Patient

  • Traditional Approach: The practice recommends fractional non-ablative or ablative lasers, which the patient declines due to fear of post-inflammatory hyperpigmentation and prolonged erythema. Dermal fillers are also ruled out due to worries about fluid retention, swelling, or visibility through thin skin.

  • Adopting the DS 10-1.5N Protocol: The clinic implements a superficial MFU-V pass across the infra-orbital hollow margins. The narrow focal zone stimulates localized dermal tightening beneath intact skin, keeping surface redness minimal and transient.

Use Case 3: Perioral Barcode Lines with Existing Fillers

  • Traditional Approach: Repeatedly injecting dermal fillers into the upper lip risks over-projecting the area, altering the vermilion border, or creating micro-lumpiness. Ablative skin resurfacing requires extensive recovery.

  • Adopting the DS 10-1.5N Protocol: The provider performs a deep structural pass using a 3.0 mm transducer, followed by concentric superficial lines around the lips using the DS 10-1.5N. This sequence refines vertical lines and supports tissue longevity without introducing excessive artificial volume.

Operational Impact and Financial Payback Math

Investing in the DS 10-1.5N handpiece requires evaluating its direct operational and financial footprint on a clinic’s existing capital framework.

Pricing Context and Consumable Structures

Market valuations for brand-new, original Ulthera transducers generally track between 1,500 USD and 2,500 USD per cartridge, depending on distribution channels and regional compliance. Certified pre-owned (CPO) or surplus units featuring verified partial line counts often transact at lower price points.

Every new DS 10-1.5N cartridge contains a finite allocation of approximately 2,400 acoustic lines. Depending on treatment density and protocol layout, a standard periorbital and perioral superficial session consumes enough lines to yield roughly 3 to 4 complete patient procedures per transducer. This sets a base consumable amortization cost of approximately 50 USD to 150 USD per patient for the superficial treatment layer.

When positioned as a high-value, specialized add-on to an existing full-face lifting package, practices can realistically price a periorbital/perioral polishing session between 150 USD and 400 USD. Consequently, a single cartridge can generate thousands of dollars in incremental revenue over its operational lifespan. True payback velocity depends on local patient demographics, treatment bundling strategies, and whether the service attracts new client segments who prioritize fine-line mitigation over structural lifting.

Practice Optimization

Integrating this specialized cartridge introduces specific operational variables:

  • A measured increase in total procedural time to accommodate detailed, high-precision passes around the eyes and lips.

  • An increased emphasis on staff training to ensure accurate cross-sectional imaging and meticulous transducer alignment.

  • The opportunity to offer clearly tiered protocol menus (e.g., Core Structural Lifting vs Premium Lift & Polish), matching treatment costs to specific patient expectations.

ALLWILL helps practices model specific per-shot costs and protocol economics based on projected patient volumes and line densities. This ensures that every cartridge purchase aligns with a calculated practice development strategy.

Biomedical Engineering Maintenance Checklist

Because transducers function as specialized consumable hardware, keeping them operational requires structured oversight. The following technical checklist helps biomedical engineering teams preserve performance standards and manage operational life.

1. Identity and Console Recognition

Verify that the model designation (DS 10-1.5N), factory serial number, lot tracking, and transducer subtype (UT-4N) align with procurement records. Confirm that the core system correctly reads the cartridge data upon connection to prevent counterfeit or incompatible components from entering clinical service.

2. Regulatory Alignment and Indications

Cross-reference current instructions for use (IFU) against local regulatory clearances. In specific jurisdictions like the United States, the system holds clearances for lifting the brow, lax submental/neck tissue, and treating décolleté wrinkles. Framing specialized periorbital polishing as a precise technique requires distinguishing marketing terminology from primary indications for use according to regional guidelines.

3. Visual and Structural Inspection

Examine the acoustic coupling membrane, outer plastic housing, product labeling, and cable strain reliefs prior to clinical use. Check for micro-fractures, punctures, housing discoloration, or signs of internal fluid leakage. Cartridges showing physical degradation must be retired immediately to prevent distorted acoustic fields or surface burns.

4. Electrical Safety Verification

Conduct regular leakage current testing, ground continuity assessments, and insulation integrity verifications according to IEC 60601-1 standards. Confirm that Type B applied part insulation pathways are secure to eliminate residual shock or unintended thermal risks near delicate ocular anatomy.

Also check:  Which Laser Tattoo Removal Machine Offers the Best Clinic ROI?

5. Acoustic Output Performance Baseline

Perform standard manufacturer calibration validations or phantom tissue simulation checks to confirm that the acoustic output stays within the specified ±20% energy accuracy tolerance. Ensure the focal depth stays centered at 1.5 mm to maintain uniform treatment lines.

6. Thermal Cutoff Management

Verify the operational status of the internal temperature sensors during test sequences. The Ulthera software disables active scanning if internal transducer temperatures reach approximately 43°C. Tracking this behavior protects the internal crystal arrays during high-density passes.

7. Line-Count Logging and Auditing

Establish a mandatory tracking ledger to log initial and concluding line counts after every treatment session. Tracking line consumption prevents surprise downtime mid-procedure and generates empirical cost-per-shot metrics for accounting reviews.

8. Cleaning and Disinfection Control

Enforce approved sanitization protocols using compatible, non-corrosive disinfectant wipes. Never submerge electrical connectors or expose the acoustic membrane to harsh solvents, which can cause micro-cracking and degrade the beam profile.

9. Sourcing Strategy and Replacement Planning

Maintain a proactive procurement schedule based on historical clinic case volumes. Balancing a combination of new and certified pre-owned cartridges with verified line counts allows clinics to maintain constant inventory levels without overextending capital.

Sourcing Pitfalls and ALLWILL Expert View

Navigating the secondary market for high-demand aesthetic consumables introduces specific logistical and technical risks that require careful management.

Procurement Pitfalls to Evade

Practices sourcing DS 10-1.5N cartridges frequently encounter predictable acquisition errors:

  • Unverified Line Count Claims: Purchasing secondary units marketed with generic lifespan percentages without checking console-verified screenshots or official service logs can result in distorted cost-per-treatment metrics.

  • Mismatched Model Configurations: Confusing the standard broad-footprint DS 10-1.5 with the narrow-footprint DS 10-1.5N compromises treatment precision around curved bony structures and may void equipment warranties.

  • Fragmented Supply Chains: Sourcing components through unverified brokers increases exposure to counterfeit accessories, leading to irregular beam shapes and elevated clinical risk profiles.

ALLWILL Expert View

From a clinical asset planning perspective, the ULTHERA DS 10-1.5N should be treated as a precision micro-instrument that optimizes the earning capacity of an existing console. Practices should begin by auditing their current patient demographics to identify clients seeking correction for fine periorbital crepiness, rather than waiting for full-face lifting indications. This data allows for the creation of standardized, high-margin treatment tiers.

On the logistics front, the most sustainable approach is separating device acquisition from immediate clinical demand. Instead of purchasing replacement cartridges on an ad-hoc basis when an active probe runs out, practices can coordinate a rolling procurement plan that blends new and certified pre-owned units. Sourcing through a platform like ALLWILL ensures every transducer undergoes engineering inspection and line validation via an advanced Smart Center. This approach transforms consumable procurement from an unpredictable operational expense into a stable, strategic revenue driver.

Frequently Asked Questions

What is the typical price range for a DS 10-1.5N transducer?

New Ulthera DS 10-1.5N cartridges generally track between 1,500 USD and 2,500 USD based on global location and distribution channels. Certified pre-owned units with verified remaining line counts trade at lower price levels, with pricing scaling according to remaining line metrics and warranty coverage.

How does a certified pre-owned DS 10-1.5N differ from a new one?

Certified pre-owned transducers undergo multi-point technical inspections, functional calibration testing, and physical grading to verify remaining line allocations. While functionally compliant with performance specifications, they are not identical to factory-new units and typically carry structured warranties provided by the secondary vendor or B2B platform rather than the original manufacturer. Furthermore, their initial software handshakes with the core console may reflect a reduced operational line pool, which requires precise tracking via your internal logistics ledger to ensure accurate clinical cost-per-shot modeling.

How many patient procedures can be performed with a single DS 10-1.5N cartridge?

Every new cartridge contains an allocation of approximately 2,400 acoustic lines. Depending on individual treatment density and whether you are covering both the periorbital and perioral zones, a standard superficial refinement protocol consumes enough lines to yield roughly 3 to 4 complete patient procedures per transducer.

Can the DS 10-1.5N be used as a standalone solution for facial lifting?

No, the DS 10-1.5N operates at a shallow 1.5 mm depth targeting the superficial dermis to refine fine lines and texturing. It does not reach the deeper SMAS layer or deep subcutaneous tissue. For comprehensive structural lifting, it must be deployed as a final “polishing” layer complementing deeper 4.5 mm and 3.0 mm Ultherapy transducers.

admin5

联系我们|Contact Form

TERMS AND CONDITIONS 

These Terms and Conditions (these “Terms”), together with the attached or accompanying quote page (the “Quote,” collectively, this “Agreement”), exclusively govern the sale by Healthcare Markets, Inc., a Delaware corporation doing business as “Powered by MRP” (“MRP”), and the purchase and use by the buyer set forth on the Quote (“Buyer”), of the equipment (the“Equipment”) and/or services (the “Services”).

        1.  EQUIPMENT AVAILABILITY. Equipment offered for sale by MRP is subject to availability. MRP shall not be liable to Buyer in case of stock outage or unavailability of the Equipment. MRP reserves the right to change the equipment offered for sale at any time and without notice to Buyer. Availability of equipment may be determined when an order is placed, and, if unavailable, MRP will inform Buyer of such unavailability, offer other available equipment as substitution or cancel the order. Such cancelled order will be refunded by MRP to Buyer, except for an order for a Special Order Product, which cannot be cancelled once the order is placed.

        2.  PRICES. Written price quotations on the Quote shall last for ten (10) days from the date issued and then automatically expire, and quoted prices do not include taxes, freight, handling, duty, insurance or other similar charges, which Buyer must pay unless waived in writing by MRP or a valid tax exemption certificate is provided to MRP. Notwithstanding the foregoing, all published prices may be changed by MRP at any time without notice to Buyer.

        3.  TERMS OF PAYMENT. Unless otherwise agreed to on the Quote or in writing by MRP, prepayment in full is required, by bank transfer, cash, credit card or certified check, and where partial pre-payment is permitted, such payment shall be nonrefundable with the balance due net thirty (30) days from the date of invoice. MRP reserves the right to modify or revoke any credit previously extended. Past due balances shall be subject to a service charge of one and one-half percent (1.5%) per month, not to exceed the maximum amount permitted by applicable law. Buyer agrees to pay all fees, charges or other sums payable hereunder, including collection fees incurred, with no right of set-off or reduction of any nature unless approved in writing by an MRP corporate officer (an “MRP Officer”). Buyer hereby grants, and MRP reserves, a purchase money security interest in the Equipment purchased, and in any proceeds thereof, to secure Buyer’s payment obligations hereunder. Buyer shall cooperate fully with MRP to execute such documents and accomplish such filings and/or recordings as MRP may deem necessary for the protection of its interests in the Equipment furnished to Buyer, and in the event Buyer does not aid within a reasonable time after MRP asks Buyer to do so, Buyer hereby authorizes and appoints MRP as Buyer’s attorney-in-fact to execute, deliver and file at any time, any financing statement and/or take any other action permitted by applicable law to perfect, enforce, continue and amend MRP’s security interest in any jurisdiction deemed appropriate by MRP. Buyer agrees that upon nonpayment of any charges due to MRP, MRP may cancel or delay delivery of the Equipment and/or suspend any applicable service coverage, which may resume only when MRP receives payment in full, and the warranty period will continue to run during such time of nonpayment although warranty service will not be available.

        4.  SHIPMENT AND DELIVERY. Delivery dates are estimated, and partial deliveries are allowed. MRP shall not be liable for or in respect of any loss or damage arising from any delay in filling any order, failure to deliver or delay in delivery. No delay in the shipment or delivery of any Equipment relieves Buyer of its obligations under this Agreement, including, without limitation, accepting delivery of any remaining installment(s) of the Equipment, if applicable. Buyer must pay for, and hold MRP harmless from, all shipping, delivery, and insurance expenses unless otherwise agreed in writing by an MRP Officer or otherwise indicated on the Quote. MRP will not assume any liability if MRP selects the shipping methods nor will any carrier be deemed to be MRP’s agent. “Time is of the essence” terms will not apply to orders accepted by MRP. Title and risk of loss of the Equipment shall pass to Buyer, and delivery shall be deemed completed, when the Equipment is delivered to Buyer’s address. Should loss or damage in transit occur, Buyer’s payment obligations will not be affected. Buyer is liable for all costs for MRP’s holding or storing of the Equipment if delivery is delayed by Buyer or at Buyer’s request. If delivery is delayed over thirty (30) days, MRP may, at its option and upon notice to Buyer, cancel that and all future deliveries without further liability or obligation of any kind.

        5.  FORCE MAJEURE. MRP shall not be responsible for delays or failure to render or service any Equipment and/or perform any Service due to any cause beyond MRP’s control, including, but not limited to: (a) acts of God; (b) flood, fire, earthquake, epidemic, pandemic or explosion; (c) war, invasion, hostilities (whether war is declared or not), terrorist threats or act, riot or other civil unrest; (d) government order, law or actions; (e) embargoes or blockades in effect on or after the date of this Agreement; (f) national or regional emergency; (g) strikes, labor stoppages or slowdowns or other industrial disturbances; and (h) telecommunication breakdowns, power outages or shortages, lack of warehouse or storage space, inadequate transportation services or inability or delay in obtaining supplies of adequate or suitable material (each, a “Force Majeure Event”). Any delivery date may be extended, at MRP’s sole discretion, to the extent of any delay resulting from any Force Majeure Event.

        6.  ACCEPTANCE; INSPECTION. Except for Special Order Products, Buyer shall inspect all Equipment upon delivery and within forty-eight (48) hours of delivery to Buyer shall give written notice to MRP of any error or claim that any Equipment does not conform to the terms of this Agreement; any claims not made within such period shall be deemed waived and released, with the Equipment being accepted by Buyer. Except as provided under this Section 6 and Section 7 hereof, all sales of Equipment to Buyer are made on a one-way basis, and Buyer has no right to return Equipment purchased under this Agreement to MRP. Subject to the warranty set forth in Section 8(c)(iv), Services are deemed to be accepted by Buyer upon completion of their performance by MRP.

        7.  CANCELLATION CHARGES AND RETURNED EQUIPMENT POLICY. Returns and cancellations are not permitted without written approval by an MRP Officer, which shall be made in such MRP Officer’s sole discretion. If approved, MRP will issue a return merchandise authorization number, which Buyer must include in the returned packaging, and Buyer must pay MRP either a (a) twenty percent (20%) restocking charge on the purchase price of the item if Buyer’s written request for return or cancellation is received by MRP’s headquarters after MRP’s original shipment of the Equipment or (b) a ten percent (10%) cancellation damages charge if Buyer’s request was received before said shipment. The foregoing charges are agreed upon, not as a penalty, but because of the difficulty of computing actual damages, and until the applicable charge is paid and the Equipment has been received back by MRP in new condition, no refund will be given. This document or copies hereof may be filed with the appropriate authorities as a financing statement to pursue such charges. In no case will shipping and freight costs be refunded. Removed, replaced or substituted equipment and parts (collectively, “Returned Equipment”) shall become MRP’s property, with title and ownership transferring to MRP upon the earlier of its return or replacement, with MRP owing no other obligations on the Returned Equipment. Buyer hereby agrees to indemnify, defend and hold harmless MRP Indemnitees from any claims, costs, losses, attorneys’ fees and expenses related to any third-party attempts to claim ownership of the Returned Equipment or dispute any trade-in, removal, substitution or replacement, and the remaining provisions shall continue in full force and effect.

        8.  MRP’S WARRANTIES, IF ANY.

(a) Equipment Sold “As Is.” UNLESS OTHERWISE STATED ON THE QUOTE OR IN A WRITING SIGNED BY AN MRP OFFICER, BUYER AGREES THAT THE EQUIPMENT SOLD IN THIS AGREEMENT IS BEING SOLD ON AN “AS IS,” “AS AVAILABLE” BASIS, SUBJECT TO SECTIONS 8(c) AND 9, AND HAVE NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, WHETHER IMPLIED OR ARISING BY LAW, STATUTE OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, NON-INFRINGEMENT, WORKMANLIKE MANNER, QUALITY, ACCURACY, TITLE, AND/OR IMPLIED FROM A COURSE OF DEALING OR PERFORMANCE USAGE IN TRADE.

(b) Special Order Product. If this Agreement includes the sale of a product that MRP does not currently have or typically keep in stock, in MRP’s sole determination, but is acquired from a third party specifically for Buyer (a “Special Order Product”), then Buyer agrees that (i) Buyer, at its sole discretion, has made the selection of such Special Order Product, (ii) such Special Order Product is being acquired by MRP solely at the request of Buyer, (iii) no representation, warranty or guarantee has been made by MRP with respect to such Special Order Product, (iv) the obligation of Buyer to pay MRP for the Special Order Product is absolute and unconditional, and (v) Buyer waives and releases MRP from all claims, damages and losses arising out of such Special Order Product. Special Order Products carry no right to inspection before or after delivery, and MRP is not responsible for examining or evaluating such Special Order Products. MRP makes no warranty about Special Order Products and offerings of the third party (including description of the Special Order Product). MRP does not assume any responsibility or liability for the actions, product and content of all these and any other third parties. If there are any problems with any Special Order Product, Buyer must contact the manufacturer of such Special Order Product for assistance.

(c) Limited Warranties, If Any.

(i) If the Quote expressly states that the Equipment has a warranty for a certain time (a “Warranty Period”), then MRP warrants that the Equipment shall be in good working order under normal use for the Warranty Period, which Warranty Period shall commence from the date of delivery to Buyer (the “Delivery Date”), unless otherwise approved by an MRP Officer in writing, except for the following: (A) New (not used or pre-owned) Equipment that is to be serviced by MRP: if the Quote is silent, warranted to be in good working order under normal use for one hundred eighty (180) days from the Delivery Date; (B) Used Equipment sold refurbished by MRP: if the Quote is silent, warranted to be in good working order under normal use for thirty (30) days from the Delivery Date; (C) Consumable/disposable Equipment: if the Quote is silent, warranted to have been shipped from MRP in functional condition, and no additional warranty shall apply; no service shall be provided either. These items should be inspected for obvious damage, subject to Section 6 and 8(e), and MRP’s obligation under this warranty and this Section 8(c)(i)(C) is limited to replacement of the Equipment; and (D) New (not used or pre-owned) Equipment that is to be serviced by the manufacturer: if the Quote is silent, MRP makes no warranty for any such Equipment. Buyer’s sole warranty for any such Equipment, if any, shall be the original manufacturer’s warranty, which MRP agrees to pass on to Buyer, as applicable. (ii) For the limited warranties of Section 8(c)(i), including exceptions (A) and (B), but not (C) or this (D), Buyer is entitled to telephone, e-mail and video technical assistance and, subject to Sections 8(d) and 8(e), repair or replacement of such Equipment, in MRP’s sole discretion, should the Equipment become inoperative through normal use during the Warranty Period. Loaner equipment is not provided, but if so arranged by MRP, Buyer shall pay MRP the cash list price of any unreturned loaner equipment provided by MRP within seven (7) days of a written demand from MRP. (iii) Repair or replacement under any limited warranty of Equipment may be with parts or products that are new, used or refurbished, carrying the same limited warranty for the remaining term of the original item. Repairs or replacements shall not interrupt, extend or prolong the term of the warranty. (iv) For Services purchased under this Agreement, MRP warrants that the Services shall be performed using competent personnel in a professional manner in accordance with generally recognized industry standards for similar services. Subject to Sections 6 and 8(e) herein, if any Service was not performed in accordance with the aforementioned warranty, then MRP shall, in its sole discretion, either (A) repair or re-perform the applicable Service, or (B) credit or refund the price of such Service at the pro rata contract rate.

(d) Exclusions. MRP reserves the right, without liability, to void all warranties and remedies, including any obligation to service, repair, replace or otherwise remedy defects, errors or failures of the Equipment due to the occurrence of any of these events, and MRP shall be in no way responsible for: (i) handling, maintenance or use in a manner that is inconsistent with and/or contrary to the original manufacturer’s or MRP’s recommended procedures and/or instructions, including, without limitation, use of or with an unauthorized third-party good or part; (ii) any failure or damage resulting from negligence, alteration, modification or relocation of the Equipment by Buyer, its employees, agents or representatives; (iii) attempted or actual unauthorized dismantling, disassembling, service, repair, addition or change of the Equipment, including, without limitation, changing the serial number or shot count; (iv) abnormal wear and tear, including, without limitation, use under abnormal conditions (e.g., unclean, dusty, or exposure to extreme electromagnetic radiation, temperature or humidity); or (v) damage or failure of the Equipment due to a Force Majeure Event or a problem in the premises of the Equipment. In any of the above situations, or for any Equipment that has no warranty, MRP has sole discretion to service the Equipment, at Buyer’s expense, at MRP’s then-in-effect rates for service, labor, travel, shipping and materials.

(e) Notice and Inspection. The limited warranties contained in this Section 8 are made on condition that immediate written notice of any noncompliance with the Equipment’s and/or the Service’s warranty be given to MRP, and provided that MRP’s inspection reveals that Buyer’s claim is valid under the terms of such warranty.

        9.  DISCLAIMERS; NO OTHER WARRANTY. EXCEPT TO THE EXTENT AS PROVIDED IN SECTION 8(c)(i)(D), BUYER ACKNOWLEDGES THAT MRP IS NOT BOUND BY ANY WARRANTY THAT MAY BE SET FORTH IN A MANUFACTURER’S WRITTEN MATERIALS THAT WOULD HAVE APPLIED HAD BUYER PURCHASED THE EQUIPMENT DIRECTLY FROM THE MANUFACTURER IN ITS UNUSED STATE. BUYER ACKNOWLEDGES THAT BUYER HAS NOT RELIED UPON ANY WARRANTY OTHER THAN AS SET FORTH IN THIS AGREEMENT. IN ADDITION, BUYER ALSO HEREBY ACKNOWLEDGES AND AGREES THAT ANY ORAL OR WRITTEN STATEMENTS CONCERNING USE AND REGULATION OF MEDICAL DEVICES SOLD BY MRP ARE AND SHALL BE CONSTRUED AS FOR INFORMATIONAL PURPOSES ONLY AND WITHOUT WARRANTY OR ASSURANCE BY MRP AS TO THEIR ACCURACY OR VALIDITY. MRP ALSO HEREBY DISCLAIMS ANY AND ALL WARRANTIES REGARDING OTHER MEDICAL CARE OR HELP, INCLUDING THE SELECTION OF AESTHETIC AND MEDICAL PROCEDURES AND PRODUCTS FOR, OR CARE OF, PATIENTS. THE LIMITED WARRANTIES OF THIS AGREEMENT, IF APPLICABLE TO ANY EQUIPMENT OR SERVICE FURNISHED UNDER THIS AGREEMENT, CONSTITUTE THE ONLY WARRANTIES MADE WITH RESPECT TO THE EQUIPMENT AND/OR SERVICE AND ANY DEFECT, DEFICIENCY OR NONCONFORMITY. TO THE EXTENT PERMITTED BY LAW, SUCH WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE, INCLUDING, BUT NOT LIMITED TO, ANY EXPRESS OR IMPLIED WARRANTY OF MERCHANTABILITY, TITLE, NONINFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE.

        10.  LIMITATION OF LIABILITY. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, UNDER NO CIRCUMSTANCES SHALL MRP BE LIABLE FOR ANY INDIRECT, PUNITIVE, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY OR SPECIAL DAMAGES, ARISING FROM, RELATED TO OR CAUSED, DIRECTLY OR INDIRECTLY, WHETHER FORESEEABLE OR NOT, BY THE EQUIPMENT AND/OR THE SERVICES, THE USE OR INABILITY TO USE THE EQUIPMENT, THE RESULTS GENERATED FROM THE EQUIPMENT AND/OR THE SERVICES, THIS AGREEMENT, ANY OTHER ACT OR OMISSION OF MRP, OR BASED UPON ANY OTHER LEGAL THEORY. IN NO EVENT SHALL MRP BE LIABLE FOR ANY LOSSES OF REVENUE, USE, BUSINESS OPPORTUNITY, PROFIT, SAVINGS OR ANY OTHER DAMAGES DUE TO ANY CAUSE WHATSOEVER, EVEN IF MRP OR ITS AGENTS HAS BEEN ADVISED OF THE POSSIBILITY THEREOF. THE FOREGOING IS A SEPARATE, ESSENTIAL TERM OF THIS AGREEMENT, AND SHALL BE EFFECTIVE UPON THE FAILURE OF ANY REMEDY, EXCLUSIVE OR NOT. IN NO EVENT WILL MRP’S TOTAL LIABILITY UNDER THIS AGREEMENT EXCEED THE PURCHASE PRICE ACTUALLY PAID TO MRP BY BUYER FOR THE EQUIPMENT AND/OR THE SERVICES GIVING RISE TO THE CLAIM FOR WHICH DAMAGES ARE BEING SOUGHT. NO SUIT OR ACTION MAY BE BROUGHT BY BUYER, ITS SHAREHOLDERS, DIRECTORS, MANAGERS, EMPLOYEES OR AGENTS FOR ANY BREACH OF THIS AGREEMENT MORE THAN ONE (1) YEAR AFTER THE ACCRUAL OF SUCH CAUSE OF ACTION. IT IS AGREED THAT MRP’S LIABILITY IS SO LIMITED. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, BUYER ASSUMES ALL RISK AND LIABILITY FOR THE RESULTS OBTAINED BY THE USE OF ANY EQUIPMENT IN THE PRACTICE OF ANY PROCESS, WHETHER IN TERMS OF OPERATING COSTS, GENERAL EFFECTIVENESS, SUCCESS OR FAILURE, AND REGARDLESS OF ANY ORAL OR WRITTEN STATEMENTS MADE BY MRP, BY WAY OF TECHNICAL ADVICE OR OTHERWISE, RELATED TO THE USE OF THE EQUIPMENT.

        11.  BUYER’S REPRESENTATIONS AND WARRANTIES. Buyer represents and warrants to MRP that: (a) Buyer is duly organized, validly existing, and in good standing in the jurisdiction of Buyer’s formation; (b) Buyer is duly qualified to do business and is in good standing in every jurisdiction in which such qualification is required; (c) Buyer has the full right, power, and authority to enter into this Agreement and to perform Buyer’s obligations under this Agreement; (d) the execution of this Agreement by the person whose signature is set forth at the end hereof has been duly authorized by all necessary corporate action of Buyer; (e) when executed and delivered by each of MRP and Buyer, this Agreement will constitute the legal, valid and binding obligation of Buyer, enforceable against Buyer in accordance with its terms; (f) Buyer is in compliance with all applicable laws relating to this Agreement, the Equipment and the operation of Buyer’s business; (g) Buyer is not insolvent and is paying all of its debts as they become due; and (h) all financial information that Buyer has provided to MRP is true and accurate and fairly represents Buyer’s financial condition.

        12. PROPRIETARY RIGHTS.

(a) Ownership. No sale shall be construed as granting to Buyer any license or other right in, or to, any of MRP’s (i) patents; (ii) trademarks; (iii) internet domain names, whether or not trademarks, registered by any authorized private registrar or governmental authority, web addresses, web pages, websites and URLs; (iv) works of authorship, expressions, designs and design registrations, whether or not copyrightable, including copyrights and copyrightable works, software and firmware, technical data, data files, and databases and other specifications and documentation; (v) trade secrets; (vi) environmental or other testing applicable to the Equipment and/or the Services; and (vii) industrial and other intellectual property rights, and all rights, interests, and protections that are associated with, equivalent or similar to, or required for the exercise of, any of the foregoing, however arising, in each case whether registered or unregistered and including all registrations and applications for, and renewals or extensions of, such rights or forms of protection pursuant to the laws of any jurisdiction throughout in any part of the world (collectively, the “Intellectual Property Rights”).

(b) Prohibited Acts. Buyer shall not (i) take any action that might interfere with any of MRP’s rights in or to Intellectual Property Rights, including MRP’s ownership or exercise thereof; (ii) challenge any right, title, or interest of MRP in or to the Intellectual Property Rights; (iii) make any claim or take any action adverse to MRP’s ownership of the Intellectual Property Rights; (iv) register or apply for registrations, anywhere in the world, for MRP’s trademarks or any other trademark that is similar to MRP’s trademarks or that incorporates MRP’s trademarks in whole or in confusingly similar part; (v) use any mark, anywhere that is confusingly

similar to MRP’s trademarks in whole or in confusingly similar part; (vi) engage in any action that tends to disparage, dilute the value of or reflect negatively on the Equipment and/or the Services or any of MRP’s trademarks; (vii) misappropriate any of MRP’s trademarks for use as a domain name without prior written consent from MRP; or (viii) alter, obscure or remove any of MRP’s trademarks, or trademark or copyright notices or any other proprietary rights notices placed on the

Equipment, marketing materials or other materials that MRP may provide.

        13.  CONFIDENTIAL INFORMATION. Without the prior written consent of MRP,Buyer, directly or indirectly, shall not disclose (and will direct its directors, shareholders, employees and agents not to disclose) any Confidential Information. The term “Confidential Information” means any information of or relating to MRP or the Equipment and/or the Services not generally known to the public (other than as a result of disclosure in violation of this Agreement) in spoken, printed, electronic or any other form or medium, including, but not limited to, business processes, practices, methods, policies, plans, publications, documents, research, operations, services, strategies, techniques, agreements, contracts, transactions, potential transactions, know-how, trade secrets, databases, manuals, records, supplier information, financial information, accounting information, legal information, marketing information, pricing information, payroll information, personnel information, and supplier lists.

        14.  NON-SOLICITATION. Buyer agrees not to solicit or hire any personnel of MRP involved with the delivery of the Services during the provision of such Services and for twelve (12) months after the completion of such Services; provided, however, that Buyer may hire individuals employed by MRP who, without other solicitation, respond to advertisements or solicitations aimed at the general public.

        15.  EQUITABLE REMEDIES. Buyer acknowledges and agrees that (a) a breach or threatened breach by Buyer of any of its obligations under Sections 13 or 14 would give rise to irreparable harm to MRP for which monetary damages would not be an adequate remedy and (b) in the event of a breach or a threatened breach by Buyer of any such obligations, MRP shall, in addition to any and all other rights and remedies that may be available to MRP at law, at equity, or otherwise in respect of such breach, be entitled to equitable relief, including a temporary restraining order, an injunction, specific performance, and any other relief that may be available from a court of competent jurisdiction, without any requirement to post a bond or other security, and without any requirement to prove actual damages or that monetary damages will not afford an adequate remedy. Buyer agrees that Buyer will not oppose or otherwise challenge the appropriateness of equitable relief or the entry by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this Section 15.

        16.  INDEMNIFICATION. Buyer agrees to indemnify, defend and hold harmless MRP and its directors, shareholders, employees and agents (collectively, “MRP Indemnitees”) against any liability, damage, loss or expense incurred by or imposed in connection with any claims, suits, actions, demands or judgments arising out of (a) any breach or non-fulfillment of any representation, warranty or covenant set forth in this Agreement by Buyer or its directors, managers, employees or agents (collectively, “Buyer’s Agents”); (b) any negligent act or omission or willful misconduct of Buyer or Buyer’s Agents in connection with this Agreement; (c) any bodily injury, death of any person or damage to real or tangible personal property caused by Buyer or Buyer’s Agents, including the use of unauthorized parts in or service of the Equipment; (d) any failure by Buyer or Buyer’s Agents to comply with any applicable laws; (e) any fraud or other intentional acts by Buyer or Buyer’s Agents; and (f) the use or operation of the Equipment, including, without limitation, any medical and/or surgical procedures performed by Buyer, and any of Buyer’s Agents, using the Equipment unless said damages are determined by a court of competence jurisdiction to be solely by the gross negligence of MRP or solely as result of a breach by MRP of the limited warranties contained herein.

        17.  DEFAULTS; REMEDIES. Notwithstanding anything herein to the contrary, should Buyer fail to pay for the order or any other amount, in whole or in part, when due or perform its other obligations under this Agreement or as otherwise mutually agreed in writing between Buyer and MRP (each, a “Default”), then MRP may take any and all actions available under law or equity to collect said amounts with a ten (10) day prior written notice, including, but not limited to, enforcing its security interest, accelerating the payment of and declaring immediately due and payable any unpaid balance of the order, referral to outside collection agencies and/or commencement of legal action. MRP’s rights shall be cumulative, and it shall not be required to have attempted to realize upon to the Equipment before taking any other collection actions. MRP may require that Buyer assemble and return any or all of the Equipment to MRP and, in the event Buyer fails to return such Equipment peaceably, enter upon the premises where such Equipment is located, with or without legal process, and repossess such Equipment. Upon a Default, Buyer agrees to pay upon MRP’s demand: (i) all costs and expenses incurred by MRP or its assignee in connection with the enforcement of any remedies, including all expenses incurred in connection with the return, sale, release or other disposition of the Equipment, including attorneys’ fees and other costs incurred by MRP or its assignee in enforcing or defending its rights and remedies under this Agreement and any other written agreement between Buyer and MRP.

        18.  COMPLIANCE WITH LAWS. Buyer shall (a) carry out the transactions contemplated by this sale and deal with the Equipment in conformity with all applicable laws, rules and regulations of all government authorities, including, without limitation, export laws, (b) obtain all permits and licenses required in connection with the purchase, shipment, installation or use of the Equipment, and (c) be solely responsible to fully understand and comply with laws, rules and regulations. Any information provided is as a convenience only.

        19.  FURTHER ASSURANCES. Upon MRP’s reasonable request, Buyer shall, at its sole cost and expense, execute and deliver all such further documents and instruments, and take all such further acts, necessary to give full effect to this Agreement.

        20.  ASSIGNMENT; SUCCESSORS AND ASSIGNS. Buyer cannot delegate any duties nor assign any rights or claims under this Agreement without MRP’s prior written consent, and any such attempt or assignment shall be void. In the event that Buyer finances its acquisition of any Equipment with a third party, Buyer may direct MRP to transfer title of such Equipment to such third-party financing company, with all remaining terms and conditions of this Agreement remaining in full force and effect. This Agreement is binding on and inures to the benefit of the parties to this Agreement and their respective permitted successors and permitted assigns.

        21.  NO THIRD-PARTY BENEFICIARIES. Subject to Section 16, this Agreement benefits solely the parties to this Agreement and their respective permitted successors and assigns, and nothing in this Agreement, express or implied, confers on any other person any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

        22.  GOVERNING LAW; VENUE. The application of the UN Convention on Contracts for the International Sale of Goods is expressly excluded. The parties agree that any and all claims, demands, disagreements, controversies or disputes arising out of or relating to this Agreement and any agreement or document delivered in connection herewith (collectively, “Claims”) shall be governed by and construed in accordance with the laws of the State of Utah and adjudicated exclusively in the state and federal courts located in or nearest to Summit County, Utah, which courts shall have the sole and exclusive jurisdiction and venue for adjudication of all Claims. The parties hereby agree upon, consent and stipulate to the jurisdiction and venue of the aforementioned courts for the adjudication of all Claims, to the exclusion of all other courts, forums and venues whatsoever.

        23.  NON-DISPARAGEMENT. Buyer shall not disparage MRP or MRP’s trademarks, websites, products or services, or display any such items in a derogatory or negative manner on any website or in any public forum or press release.

        24.  NOTICES. Any notice, demand, or communication required, permitted or desired to be given hereunder shall be deemed effectively given when personally delivered, when sent by electronic means, when received by overnight courier, or when mailed by prepaid, certified or registered mail, return receipt requested, addressed to the other party at its address set forth on the Quote or to such other address that the receiving party may designate from time to time in accordance with this Section 25.

        25.  PUBLIC ANNOUNCEMENTS. Unless otherwise stated herein, neither party shall issue a press release or otherwise advertise, make a public statement or disclose to any third-party information pertaining to the relationship arising under this Agreement, the existence or terms of this Agreement, the underlying transactions between MRP and Buyer or agent for Buyer or refer to the other party in relation to this Agreement without the other party’s prior written approval.

        26.  ENTIRE AGREEMENT; ADDITIONAL OR INCONSISTENT TERMS. Subject to Section 32, this Agreement constitutes the sole and entire agreement between the parties hereto relating to the subject matter hereof, and any unincorporated representation, affirmation of fact, course of prior dealings, promise or condition in connection therewith, or usage of the trade, shall not be binding on either party. Terms and conditions set forth which differ from, conflict with or are not included in this Agreement shall not be part of any agreement between MRP and Buyer unless both parties specifically accept such terms and conditions in writing.

        27.  WAIVER. No waiver under this Agreement is effective unless it is in writing and signed by the party waiving its right. Any waiver authorized on one occasion is effective only in that instance and only for the purpose stated and does not operate as a waiver on any future occasion. None of the following constitutes a waiver or estoppel of any right, remedy, power, privilege or condition arising from this Agreement: any failure or delay in exercising any right, remedy, power or privilege or in enforcing any condition under this Agreement; or any act, omission or course of dealing between the parties.

        28.  SURVIVAL. Subject to the limitations and other provisions of this Agreement, the representations and warranties of Buyer contained herein shall survive the expiration or earlier termination of this Agreement for a period of twelve (12) months after such expiration o termination and (b) this Section 29 and Sections 10, 12, 13, 14, 15, 16, 17, 21, 22, 23, 24, 26, and 32 of this Agreement, as well as any other provision that, in order to give proper effect to its intent, should survive such expiration or termination, shall survive the expiration or earlier termination of this Agreement. All other provisions of this Agreement shall not survive the expiration or earlier termination of this Agreement.

        29.  RELATIONSHIP OF PARTIES. Nothing in this Agreement creates any agency, joint venture, partnership or other form of joint enterprise, employment or fiduciary relationship between the parties. Neither party has any express or implied right or authority to assume or create any obligations on behalf of or in the name of the other party or to bind the other party to any contract, agreement or undertaking with any third party.

        30.  HEADINGS. The headings in this Agreement are for reference only and do not affect the interpretation of this Agreement.

        31.  ORDER OF PRECEDENCE. In the event of conflict between the Quote, a written agreement by MRP, and these Terms, the order of priority shall be: (1) the written

agreement by MRP, if only if executed by an MRP Officer, (2) the Quote and (3) these Terms, and only to the extent of the direct conflict. Notwithstanding the foregoing, MRP shall not be bound by, and specifically objects to, any terms, conditions or other provisions, both written and oral, which are different from, in addition to or inconsistent with the provisions of this Agreement which are set forth in any purchase order, receipt, acceptance, confirmation, correspondence or otherwise of, or by, Buyer. Fulfillment of Buyer’s order shall not constitute acceptance of any of Buyer’s terms and conditions and does not serve to modify or amend the terms and conditions contained herein.

        32.  SEVERABILITY. If any part of this Agreement is held to be void, illegal or unenforceable, then it shall be deemed to be severed from this Agreement and the remaining provisions shall continue in full force and effect; provided, however, that if any fundamental term or provision of this Agreement is held to be void, illegal or unenforceable, the remainder of this Agreement shall be unenforceable. Upon a determination that any term or provision is void, illegal or unenforceable, the parties shall negotiate in good faith to modify this Agreement to effect the original intent of the parties as closely as possible in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.